logo
welcome
Reuters

Reuters

Elon Musk's Neuralink receives Canadian approval for brain chip trial

Reuters
Summary
Nutrition label

80% Informative

Elon Musk's Neuralink said it has received approval to launch its first clinical trial in Canada .

The Canadian study aims to assess the safety and initial functionality of its implant which enables people with quadriplegia, or paralysis of all four limbs, to control external devices with their thoughts.

In the United States , Neuralink has already implanted the device in two patients.

VR Score

87

Informative language

91

Neutral language

77

Article tone

formal

Language

English

Language complexity

71

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links